Structural Basis for Regulation of GPR56/ADGRG1 by Its Alternatively Spliced Extracellular Domains-Reference-Cited by-同舟云学术

Structural Basis for Regulation of GPR56/ADGRG1 by Its Alternatively Spliced Extracellular Domains

Published:2016-09 Issue:6 Volume:91 Page:1292-1304
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Salzman Gabriel S.,Ackerman Sarah D.,Ding Chen,Koide Akiko,Leon Katherine,Luo Rong,Stoveken Hannah M.,Fernandez Celia G.,Tall Gregory G.,Piao Xianhua,Monk Kelly R.,Koide Shohei,Araç Demet

Funder

GM/CA@APS

National Cancer Institute

National Institute of General Medical Sciences

DOE Office of Science by Argonne National Laboratory

Brain Research Foundation

Big Ideas Generator

NIH

Publisher

Elsevier BV

Subject

General Neuroscience

Reference68 articles.

1. The adhesion GPCR Gpr56 regulates oligodendrocyte development via interactions with Gα12/13 and RhoA;Ackerman;Nat. Commun.,2015

2. β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling;Anderson;Cell,2015

3. Structures of neuroligin-1 and the neuroligin-1/neurexin-1 beta complex reveal specific protein-protein and protein-Ca2+ interactions;Araç;Neuron,2007

4. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis;Araç;EMBO J.,2012

5. Evolutionarily dynamic alternative splicing of GPR56 regulates regional cerebral cortical patterning;Bae;Science,2014

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors;2024-09-05

2. G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors;Cellular and Molecular Life Sciences;2024-09-04

3. Mechanical force induced activation of adhesion G protein–coupled receptor;Mechanobiology in Medicine;2024-09

4. Heterogeneity of tethered agonist signaling in adhesion G protein-coupled receptors;Cell Chemical Biology;2024-08

5. GPR56: A potential therapeutic target for neurological and psychiatric disorders;Biochemical Pharmacology;2024-08